CAC (gated) Algorithm vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CAC (gated) Algorithm

by Bunkerhill Health

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

Tool A specializes in the automatic detection and quantification of coronary artery calcium from non-contrast ECG-gated cardiac CT scans, aiding in general coronary artery health assessment. In contrast, Tool B focuses on the quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, providing detailed insights for heart attack risk prediction and treatment guidance. While both contribute to cardiovascular risk assessment using AI and CT imaging, they target different aspects of coronary artery disease and utilize distinct input modalities.

Choose CAC (gated) Algorithm if…

Choose the CAC (gated) Algorithm if your primary need is automated detection and quantification of coronary artery calcium from non-contrast ECG-gated cardiac CT scans. This tool is ideal for quickly assessing overall coronary artery health and for opportunistic detection of cardiovascular disease from existing scans, streamlining report generation for radiologists.

View CAC (gated) Algorithm →

Choose Autoplaque if…

Choose Autoplaque if you require detailed quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This workstation-based software is best suited for in-depth heart attack risk prediction and guiding treatment strategies by providing precise measurements of plaque characteristics and stenosis severity.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CAC (gated) Algorithm	Autoplaque
Deployment	Unknown	Workstation-based post-processing application, runs on Windows or Mac OS.
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC (gated) Algorithm

Tool A, the CAC (gated) Algorithm, is cloud-deployed and designed to integrate directly into physicians' standard workflows, pre-populating structured reports. This approach generally offers a more streamlined user experience and reduced IT overhead compared to Tool B's workstation-based post-processing application.

Clinical Value

Autoplaque

While both tools are FDA-cleared and clinically valuable, Autoplaque (Tool B) offers a more comprehensive analysis by quantifying coronary plaques and luminal stenoses from CT angiography images. This provides deeper insights for heart attack risk prediction and treatment guidance beyond the coronary artery calcium quantification offered by Tool A.

Pricing & Value

Tie

Neither Tool A nor Tool B provides transparent pricing information in their specifications. Tool A states 'contact for pricing,' and Tool B indicates 'not disclosed.' Without any pricing details, it is impossible to assess or compare their respective value propositions.

Enterprise Readiness

CAC (gated) Algorithm

Tool A explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA), alongside being cloud-deployed and part of a broader platform. Tool B does not specify BAA or HIPAA compliance and is workstation-based, making Tool A appear more prepared for enterprise-level deployment and compliance requirements.

Innovation

Autoplaque

While Tool A's tagline mentions 'Generative AI,' its core function described is CAC quantification. Tool B's focus on detailed quantitative analysis of atherosclerotic plaque and luminal stenoses from CTA represents a more advanced and complex application of AI in cardiovascular imaging, offering deeper diagnostic insights beyond simple calcium scoring.

Support & Docs

Tie

The provided structured facts do not contain any information regarding the availability or quality of support and documentation for either Tool A or Tool B. Without this crucial information, it is not possible to differentiate between the two products in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CAC (gated) Algorithm	Autoplaque
Tool Name	CAC (gated) Algorithm	Autoplaque
Company	BunkerHill Health	Cedars-Sinai Medical Center: AIM
Description	BunkerHill Health's FDA-cleared CAC (gated) Algorithm is an AI software that automatically detects and quantifies coronary artery calcium from non-contrast ECG-gated cardiac CT scans, aiding physicians in assessing coronary artery health.	Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.
Key Features	Automatic detection and quantification of coronary artery calcium (CAC); Analysis of non-contrast ECG-gated cardiac CT scans; Provides calcium segmentation and quantification; Integrates into physicians' standard workflow; Pre-populates structured reports for radiologist review and approval; Aids in assessing coronary artery health; Supports opportunistic detection of cardiovascular disease; Part of the broader Carebricks platform for AI-powered workflows	AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area

Videos

Demos, reviews, and walkthroughs featuring CAC (gated) Algorithm and Autoplaque.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What type of cardiac imaging does each tool analyze?

Tool A, BunkerHill Health's CAC (gated) Algorithm, is designed to analyze non-contrast ECG-gated cardiac CT scans. Tool B, Autoplaque by Cedars-Sinai AIM, performs quantitative analysis from CT angiography images.

What specific aspects of coronary artery disease do these tools quantify?

Tool A focuses on the automatic detection and quantification of coronary artery calcium (CAC), aiding in assessing overall coronary artery health. Tool B provides AI-powered quantitative analysis of atherosclerotic plaque and measures luminal stenoses, assisting in heart attack risk prediction and treatment guidance.

How do these tools integrate into a physician's existing workflow?

Tool A integrates into standard workflows and pre-populates structured reports for radiologist review and approval. Tool B is a workstation-based post-processing application that allows clinicians to review and edit automated vessel, plaque, and lumen segmentations.

What are the key differences in the output or measurements provided by each tool?

Tool A provides calcium segmentation and quantification to aid in assessing coronary artery health and supports opportunistic detection of cardiovascular disease. Tool B offers automated vessel, plaque, and lumen segmentation, along with measurements of vessel diameter and area, to aid in heart attack risk prediction and treatment guidance.